INTRODUCTION
============

Perianal fistula is the formation of an epithelized track between the rectum or anal canal and the perianal region. The most common cause, in as many as 90% of cases, is an infection of the cryptoglandular gland, and the remainder of the cases involve Crohn disease, trauma, malignancy, or radiotherapy. The incidence is 8.6 in 100,000 population of the world, while those in Italy and Spain are 10.4 and 23.2 in 100,000 patients, respectively. The sex ratio is 2:1 for males compared to females, and the age range is 30--50 years. In the United States, 68,000 to 96,000 new cases are reported annually \[[@b1-ac-2018-11-19]\]. Patients with perianal fistula usually complain of feeling fluid exit the anus with dirty, wet, and odorous underwear that causes discomfort and affects quality of life \[[@b2-ac-2018-11-19]\]. The diagnosis is made when an external opening in the perianal region is discovered on clinical examination. Fistulography, magnetic resonance imaging, or endorectal sonography can be employed to support the diagnosis \[[@b3-ac-2018-11-19]\]. According to the American Society of Colorectal Surgeons, complex perianal fistula is classified as intersphincteric, transsphincteric, or supra-sphincteric fistula \[[@b4-ac-2018-11-19]-[@b6-ac-2018-11-19]\].

Surgical management of perianal fistula involves removal of the internal opening of the rectum or anal canal and the track to the perianal region. The surgery can be performed in several ways. Invasive methods include fistulotomy and fistulectomy, as well as less invasive surgeries aimed to reduce the risk of sphincter injury with the use of a plug, fibrin glue, mucosal advancement, and ligation of the intersphincteric fistulous tract (LIFT) and video-assisted anal fistula surgery \[[@b1-ac-2018-11-19]\].

Management of perianal fistula using a seton has a risk of recurrence primarily due to extension of the supralevator, horseshoe-type perianal fistula, and history of previous perianal fistula surgery. Another option of perianal fistula management is fistulectomy, but this procedure requires longer wound healing and carries the same recurrence risk as fistulotomy \[[@b7-ac-2018-11-19]\].

In cases of anal fissure, administration of medications that can temporarily relax the anal sphincter decrease anorectal pressure to accelerate wound healing, and the effects are reversible after the drugs are depleted or discontinued. In cases of perianal fissure, however, the medication is continued to maintain low anorectal pressure after the wound of the fissurotomy had healed \[[@b1-ac-2018-11-19],[@b2-ac-2018-11-19]\].

The management principles for complex perianal fistula include treatment of infections, elimination of fistula tracks, prevention of recurrence, and avoidance of anal incontinence with minimal complications and short duration of hospital care. For inter- and transsphincteric fistula, fistulotomy accompanied by splicing of the anal sphincter is the preferred surgical method, followed by open wound treatment. The recurrence rate for fistulotomy is between 0%--21% of cases, with a 0%--82% incidence of incontinence. For complex perianal fistula, fistulotomy is contraindicated in patients with high-lying fistulae involving most of the internal and external anal sphincter and in women with an anterior anal fistula caused by Crohn disease (because of the risk of occurrence of fissure due to an impaired healing process caused by long-term steroids) \[[@b3-ac-2018-11-19],[@b6-ac-2018-11-19]\].

Because of the high recurrence rate and many repetitive surgeries, management of perianal fistula is expensive, leading to dissatisfaction in the service and management of perianal fistula. There are some alternative procedures in the handling of both simple and complex perianal fistulae, but because of the high rates of recurrence and incontinence, there is no consensus or agreement on surgical technique. The relatively new technique of LIFT has a 30%--60% recurrence rate, and plugging of the anal fistula has a 70%--80% recurrence rate, while the recurrence rate in "cutting Seton" and endorectal flap advancement have 30%--60% therapeutic failure with risk of incontinence up to 67%. According to Aarons, in a single, large center study, the recurrence rate of the fistulotomy technique was only 2% lower than other techniques. Temporary incontinence occurred in 3% of the fistulotomy patients in 72 months of postoperative follow-up and evaluation \[[@b8-ac-2018-11-19]\].

The recurrence of perianal fistula may be due to spasm and hypertonia persisting in the internal anal sphincter, which will interfere with the blood flow in fistulotomy wounds, resulting in disruption of the wound healing process and increased risk of recurrence \[[@b8-ac-2018-11-19],[@b9-ac-2018-11-19]\].

Combined fistulotomy and lateral internal sphincterotomy procedure
------------------------------------------------------------------

Management of perianal fistula by a combination of fistulotomy and lateral internal sphincterotomy aims to reduce spasm and hypertonia to increase blood flow to the wound after fistulotomy, improving wound healing. In our hospital, preoperative and postoperative pressure tone were performed using digital rectal examination. Preoperatively, if 1 or 2 finger(s) can be inserted into the anal canal, the sphincter is tight. After surgery, if up to 2--3 fingers can be inserted, the sphincter had been loosened. Manometry examination was not performed preoperatively because patients were in pain due to infection or abscess. Postoperatively, manometry examination was not performed because of postoperative pain.

Operative technique
-------------------

1\. After explaining that the perianal fistula will be treated with a combination of fistulotomy and a lateral internal sphincterotomy, obtain verbal and written informed consent from the patient. Do not share the informed consent data.

2\. Prepare the bowel with Fleet Phospho-soda (Combiphar, Jakarta, Indonesia) liquid on the night before surgery and Fleet enema the morning of surgery. Administer antibiotics (IV ceftriaxone 1 g and metronidazole 500 mg) one day before surgery.

3\. Conduct regional anesthesia and place the patient in the lithotomy position.

4\. Perform a physical examination with anoscope to ensure there are no perianal abscesses.

5\. Insert a mixture of hydrogen peroxide 30% and methylene blue into the external opening on the posterior of the anus to determine the internal opening, which is marked by a discharge of blue frothing liquid.

6\. Perform the first stage: the fistulotomy procedure. Place a fistula sonde from the external opening to the internal opening and make an incision using electrocautery to cut the internal and external openings of the fistula canal. Wounds to the skin and anodermal layers are left open, and secondary healing is expected.

7\. Perform the second stage: lateral internal anal sphincterotomy. Cut the skin 2 cm above the sphincter at 5 o'clock, perform lateral identification of the internal anal sphincter with a clamp, then cut the sphincter ([Fig. 1](#f1-ac-2018-11-19){ref-type="fig"}). Close the skin with an intracutaneous suture using vicryl 2-0 in order to lay open the fistula.

8\. Apply tampon to the anal canal and gauze covered with chloramphenicol ointment to the fistulotomy wounds.

Postoperative management
------------------------

1\. On the first postoperative day, the patient may drink as usual and eat porridge. Also, administer the following intravenous (IV) antibiotics: (IV) ceftriaxone 1 g twice a day, metronidazole 500 mg 3 times a day, and ketorolac 40 mg 3 times a day.

2\. On the second postoperative day, remove the anal tampon and apply antiseptic soaked with potassium permanganate.

3\. On the third postoperative day, continue the antiseptic soaked with potassium permanganate and add an ointment of chloramphenicol, allowing the healing process to occur naturally from the base of the wound to the surface or to the mucosa or anal canal.

4\. One week postoperative, perform a digital rectal examination and anal dilatation and apply chloramphenicol ointment during a follow-up appointment at the polyclinic.

5\. Continue to postoperatively evaluate the patient in the second week and 2 months at the polyclinic. At the sixth postoperative month, contact the patient via telephone to evaluate wound healing, pain, presence or absence of incontinence, and recurrence.

CASE REPORTS
============

This study has been approved by the Institutional Review Board of the Faculty of Medicine, Universitas Gadjah Mada under permit KE/FK/0955/EC/2018. The authors attest that full and informed consent was obtained from every patient who has undergone medical treatment in our hospital. The informed consent form declared that patient data or samples will be used for educational or research purposes.

Case 1
------

A 30-year-old male presented to our clinic with complaints of discharge on the rim of the anus. The patient had a history of fistulotomy surgery three times. The patient was diagnosed with complex anal fistula. Combined fistulotomy and lateral internal sphincterotomy were conducted to manage the complex perianal fistula. During the operation, estimated bleeding was around 50 mL, and the operation length was 45 minutes. Postoperatively, the patient was given intravenous ceftriaxone 1 g twice a day. The patient was hospitalized for three days. At the postoperative follow-up appointment at the polyclinic on day 7, the patient said that he had experienced pain for about 7 days, and there was anal incontinence. The patient continued to experience anal incontinence at the 14-day follow-up appointment. At the 1- and 6-month follow-up appointments, the patient had no bleeding, infection, recurrence, or anal incontinence.

Case 2
------

A 38-year-old male presented to our clinic with complaint of discharge on the rim of the anus. The patient had a history of fistulotomy surgery 2 times. The patient was diagnosed with complex anal fistula, as shown in [Fig. 2A](#f2-ac-2018-11-19){ref-type="fig"}. Combined fistulotomy and lateral internal sphincterotomy were conducted to manage the complex perianal fistula, as seen in [Fig. 2B](#f2-ac-2018-11-19){ref-type="fig"}. Estimated perioperative bleeding was around 75 mL, and the operation length was 1 hour. Postoperatively, the patient intravenously received ceftriaxone 1 g twice a day and metronidazole 500 mg twice a day. The patient was hospitalized for 3 days. At the postoperative follow-up appointment at the polyclinic on day 7, the patient said he had pain for about 7 days, and there was anal incontinence. The patient continued to experience anal incontinence at the 14-day follow-up appointment. At the 1-month ([Fig. 2C](#f2-ac-2018-11-19){ref-type="fig"}), 2-month ([Fig. 2D](#f2-ac-2018-11-19){ref-type="fig"}), and 6-month follow-up appointments, the patient had no bleeding, infection, recurrence, or anal incontinence.

Case 3
------

A 36-year-old male presented to our clinic with complaints of discharge on the rim of the anus. The patient had a 1-time history of fistulotomy surgery. The patient was diagnosed with recurrent anal fistula. The surgical procedure was performed to manage the patient. During the operation, estimated blood loss was around 75 mL, and the operation length was 1 hour. Postoperatively, the patient was given intravenous ceftriaxone 1 g twice a day. The patient was hospitalized for 2 days. At the postoperative follow-up appointment at the polyclinic on day 7, the patient said he had pain for about 4 days, and there was anal incontinence. The patient continued to experience anal incontinence at the 14-day follow-up appointment. At the 1- and 6-month follow-up appointments, the patient had no bleeding, infection, recurrence, or anal incontinence.

Case 4
------

A 34-year-old male presented to our clinic with complaints of discharge on the rim of the anus. The patient had no history of surgery. The patient was diagnosed with complex anal fistula. Combined fistulotomy and lateral internal sphincterotomy were conducted to manage the complex perianal fistula. During the operation, the estimated bleeding was around 50 mL, and the operation length was 1 hour. Postoperatively, the patient was given intravenous ceftriaxone 1 g twice a day. The patient was hospitalized for 3 days. At the postoperative follow-up appointment at the polyclinic on day 7, the patient complained of pain for about 5 days, and there was anal incontinence. The patient continued to experience anal incontinence at the 14-day follow-up appointment. At the 1- and 6-month follow-up appointments, anal incontinence persisted. The patient was still experiencing anal incontinence at 14 weeks postoperative.

Case 5
------

A 36-year-old male presented to our clinic with complaints of discharge on the rim of the anus. The patient had a history of one fistulotomy surgery. The patient was diagnosed with recurrent anal fistula, as seen in [Fig. 3A](#f3-ac-2018-11-19){ref-type="fig"}. Combined fistulotomy and lateral internal sphincterotomy were conducted to manage the recurrent anal fistula as in [Fig. 3B](#f3-ac-2018-11-19){ref-type="fig"}. During the operation, estimated blood loss was around 50 mL, and the operation length was 45 minutes. Postoperatively, the patient was given intravenous ceftriaxone 1 g twice a day. The patient was hospitalized for 2 days. At the postoperative follow-up appointment at the polyclinic on day 7, as seen in [Fig. 3C](#f3-ac-2018-11-19){ref-type="fig"}, the patient stated he had pain for about 3 days, and there was anal incontinence. The patient had no anal incontinence at the 14-day follow-up appointment. At the 1-month, 3-month ([Fig. 3D](#f3-ac-2018-11-19){ref-type="fig"}), and 6-month follow-up appointments, the patient had no bleeding, infection, recurrence, or anal incontinence.

Here we present a summary table of the characteristics from each case ([Table 1](#t1-ac-2018-11-19){ref-type="table"}).

DISCUSSION
==========

Our hospital is a national referral hospital, and we often receive patients with residual or complex perianal fistulae that cannot be effectively managed in lower-grade hospitals. Perianal fistula, a colorectal disorder that is so clinically and psychologically disturbing that it requires comprehensive treatment, has an incidence rate of 10/1,000 people around the world. Our patients usually complain of fluid at the edges of the anus, itching, and sometimes pain with fever due to recurrent perianal infections or abscesses. The management of perianal fistula in surgical techniques and nonoperative management is challenging due to high recurrence and postoperative fecal incontinence \[[@b6-ac-2018-11-19]\]. At our referral hospital, 60% of patients present with recurrence, 30% have a simple fistula, and 10% of patients present with a complex fistula.

The postsurgical incidence rate of anal incontinence varies as follows: 0%--25% of patients suffer from flatus incontinence, 0%--17% suffer from fecal incontinence, and more than 40% suffer from passive incontinence. The incidence of incontinence depends on the type of surgical procedure, the type and complexity of the fistula, the presence of risk factors for incontinence (age, sex, history of operations before the onset perianal fistula), and other factors. With a success rate of wound healing ranging from 74%--100%, fistulotomy is still the preferred surgical technique for treatment of perianal fistula, although there have been reported recurrences and occurrences of anal incontinence in cases of complex perianal fistulae \[[@b6-ac-2018-11-19]\]. Other research described the LIFT technique as safe and easy to perform, with low morbidity, no occurrence of incontinence, and a success rate greater than 70% \[[@b7-ac-2018-11-19]\].

In the present case report, we described patients with both recurrent and complex perianal fistulae who presented with both initial and relapsed fistulae, and we performed a combination fistulotomy with lateral internal sphincterotomy to maximally decrease the anorectal pressure to facilitate wound healing from sufficient blood flow as well as prevent recurrence. The major postoperative complaint from patients is pain in the perianal region approximately 1 week after surgery. Two weeks after treatment, the wound from the lateral internal sphincterotomy is closed, and the wounds from fistulotomy with open treatment will close at 6 weeks. The primary outcome was complete healing, and the secondary outcome was freedom from incontinence. The patients reported easier defecation and no need to hard strain, a risk factor for anal mucosa laceration, abscess infection, and recurrence of perianal fistulae. Furthermore, the present report is a preliminary study for the surgical techniques in the treatment of complex and recurrent perianal fistulae. Further large-scale studies are needed to strengthen the evidence.

In conclusion, our primary study report showed that the combination of fistulotomy and lateral internal sphincterotomy is a safe procedure for recurrent and complex perianal fistulae. In 6 months of follow-up, there were no reports of recurrence or incontinence. Furthermore, a multicenter study with a larger sample of patients and longer follow-up data is necessary to clarify and confirm our findings.
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![Combination of fistulotomy and contralateral internal sphincterotomy.](ac-2018-11-19f1){#f1-ac-2018-11-19}

![Complex anal fistula. (A) Preoperative state with multiple complex anal fistulae, (B) intraoperative state, (C) 1-month postoperative follow-up, and (D) 2-month postoperative follow-up.](ac-2018-11-19f2){#f2-ac-2018-11-19}

![Recurrent anal fistula. (A) Preoperative state, (B) intraoperative state, (C) postoperative state, and (D) 3-month follow-up.](ac-2018-11-19f3){#f3-ac-2018-11-19}

###### 

Case summary

  No   Sex    Age (yr)   Diagnosis                External opening               Internal opening                                                        Cause                        Previous surgery   Postoperative (follow-up)                       
  ---- ------ ---------- ------------------------ ------------------------------ ----------------------------------------------------------------------- ---------------------------- ------------------ --------------------------- -------- ---------- ----
  1    Male   30         Complex anal fistula     Single right posterior         Single right posterior^[a](#tfn1-ac-2018-11-19){ref-type="table-fn"}^   Infection/perianal abscess   3 Times            Transsphincteric            5 Days   14 Days    No
  2    Male   38         Complex anal fistula     Single left posterior          Single left posterior^[a](#tfn1-ac-2018-11-19){ref-type="table-fn"}^    Infection/perianal abscess   2 Times            Transsphincteric            7 Days   14 Days    No
  3    Male   36         Recurrent anal fistula   Multiple (6) left posterior    Single left posterior^[a](#tfn1-ac-2018-11-19){ref-type="table-fn"}^    Infection/perianal abscess   1 Time             Transsphincteric            4 Days   14 Days    No
  4    Male   34         Complex anal fistula     Multiple (2) right posterior   Single right posterior^[a](#tfn1-ac-2018-11-19){ref-type="table-fn"}^   Infection/perianal abscess   No                 Transsphincteric            5 Days   14 Weeks   No
  5    Male   50         Recurrent anal fistula   Single left posterior          Single left posterior^[a](#tfn1-ac-2018-11-19){ref-type="table-fn"}^    Infection/perianal abscess   1 Time             Transsphincteric            3 Days   10 Days    No

Above the dentate line.
